| Product NDC: | 0091-4085 |
| Proprietary Name: | VERELAN PM |
| Non Proprietary Name: | verapamil hydrochloride |
| Active Ingredient(s): | 100 mg/1 & nbsp; verapamil hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0091-4085 |
| Labeler Name: | UCB, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020943 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19981125 |
| Package NDC: | 0091-4085-01 |
| Package Description: | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0091-4085-01) |
| NDC Code | 0091-4085-01 |
| Proprietary Name | VERELAN PM |
| Package Description | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0091-4085-01) |
| Product NDC | 0091-4085 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | verapamil hydrochloride |
| Dosage Form Name | CAPSULE, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 19981125 |
| Marketing Category Name | NDA |
| Labeler Name | UCB, Inc. |
| Substance Name | VERAPAMIL HYDROCHLORIDE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |